Company Overview of Theraclone Sciences, Inc.
Theraclone Sciences, Inc., a discovery-stage biotech company, develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. It provides In-Situ Therapeutic Antibody Rescue technology, which allows for the rapid testing of human antibodies to find those with exceptional biological functions and activities; and TCN-032, a recombinant human monoclonal antibody for the treatment of patients hospitalized with serious influenza. The company has antibody programs at preclinical and clinical development stage targeting serious medical conditions with a significant unmet medical need, including triple negative and endocrine treatment resistant HER-2 negative breast cancer...
1124 Columbia Street
Seattle Life Sciences Building
Seattle, WA 98104
Founded in 2004
Key Executives for Theraclone Sciences, Inc.
Chief Executive Officer and Director
Founder and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2015.
Theraclone Sciences, Inc. Key Developments
Wellcome Trust Selects Theraclone Sciences, Inc.'s I-STAR™ Technology to Identify Therapeutic Antibodies Against Ebola Virus
Apr 30 15
Theraclone Sciences, Inc. announced that its I-STAR™ Technology chosen by Wellcome Trust to identify Therapeutic Antibodies against Ebola Virus. The company will identify potential therapeutic antibodies against the Ebola virus utilizing the Company’s powerful human memory B-cell interrogation platform. The I-STARTM technology can rapidly screen antibodies from survivors of Ebola to uncover those with exceptional biologic activity that may lead to the development of a therapeutic antibody. BIO Ventures for Global Health was instrumental in forming a consortium of Ebola experts for the endeavor, and will collaborate with Theraclone on management of the project. To fund the initial screening and development efforts, Theraclone will receive up to $4.4 million in a Series C financing, which includes an investment from the Wellcome Trust along with existing investors.
Theraclone Sciences, Inc. Presents at BIO-Europe Spring 2015, Mar-10-2015 11:20 AM
Jan 29 15
Theraclone Sciences, Inc. Presents at BIO-Europe Spring 2015, Mar-10-2015 11:20 AM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Theraclone Sciences, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 through Feb-10-2015
Jan 19 15
Theraclone Sciences, Inc. Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 through Feb-10-2015. Venue: The Waldorf Astoria, New York, New York, United States. Presentation Date & Speakers: Feb-10-2015, Clifford J. Stocks, Chief Executive Officer and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
April 24, 2015